Sector Investment 3 Days

Last updated: May 13, 2026, 2:30 AM ET

Real Estate Investment & Strategy Shifts

A palpable tension between public and private real estate markets is emerging as major players signal aggressive fundraising and deal execution. Brookfield Asset Management, through its President, anticipates executing approximately $20bn in real estate transactions over the next two months, citing a "very rapid acceleration" in the asset class’s recovery. Concurrently, the world’s largest data center REIT by footprint, Digital Realty, is preparing a significant private capital offensive, targeting up to $3bn for a cornerstone raise in a forthcoming US open-end fund, signaling a major pivot toward private markets Digital Realty is plotting a fundraising expansion. In Europe, BNP Paribas Asset Management Alternatives has successfully amassed €3bn for a new credit strategy focused on transitional real estate, aiming for high single-digit Internal Rates of Return by providing transitional financing. Furthermore, AEW Europe is actively seeking to diversify its product range beyond traditional core/core-plus offerings under its new CEO, Vanessa Roux-Collet.

The Asia-Pacific region is also seeing targeted capital deployment and strategic real estate expansion. Pro-invest initiated a new hospitality strategy by acquiring the A$100m Coogee Sands Hotel & Apartments near Sydney, with plans to reposition the asset into other forms of temporary accommodation. Meanwhile, Japanese buyout specialist Advantage Partners is leveraging its recent expansion into real estate to target corporate-owned properties as it seeks to double its Assets Under Management. Separately, the UK market is seeing infrastructure capital flow, with Newcore securing about £100m in equity commitments for the first close of its sixth social infrastructure fund.

Sector Focus & Regulatory Drivers

Investment strategies are being refined based on sector specialization and regulatory changes, particularly in healthcare and housing. Within pharmaceuticals, oncology continues to command the lion’s share of national drug spend, accounting for roughly 40%, with retina being a close second, suggesting investment ecosystems are being built around these high-spend areas by distributors Follow the Drug Spend. On the regulatory front, potential reforms in Australia could unlock significant capital for affordable housing, as regulators weigh introducing an ‘emerging covered asset class’ to overhaul performance testing requirements Aussie performance test overhaul.